SCHEMBL20140212

SCHEMBL20140212

O=C(O)n1ccc(CCCC2CCc3cccnc3N2)n1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 9/20 0.33
ITGB3 P05106 1/20 0.31
ITGAV P06756 1/20 0.31
ITGB5 P18084 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141062 0.86 FNTA (0.33) IDH1ITGAV
SCHEMBL24521894 0.84 HDAC1 (0.33) IDH1ITGB3ITGAVITGB5
SCHEMBL24521883 0.84 HDAC1 (0.33) IDH1ITGB3ITGAVITGB5
SCHEMBL20140045 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL20140041 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL20140049 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL20141294 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL20153509 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL21294622 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5
SCHEMBL29797302 0.78 ITGB3 (0.40) ITGB3ITGAVITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538525-A1 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS Bristol-Myers Squibb Company (US) 2019-09-18 EP disclosed
WO-2018089353-A1 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed